130 related articles for article (PubMed ID: 1852100)
1. Fibrocystic disease of the breast in premenopausal women: histohormonal correlation and response to luteinizing hormone releasing hormone analog treatment.
Monsonego J; Destable MD; De Saint Florent G; Amouroux J; Kouyoundjian JC; Haour F; Breau JL; Israel L; Comaru-Schally AM; Schally AV
Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1181-9. PubMed ID: 1852100
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of cyproterone acetate or a long-acting LHRH agonist in polycystic ovarian disease.
Schaison G; Couzinet B
Horm Res; 1987; 28(2-4):169-74. PubMed ID: 2969860
[TBL] [Abstract][Full Text] [Related]
3. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats.
Horvath JE; Bajo AM; Schally AV; Kovacs M; Herbert F; Groot K
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15048-53. PubMed ID: 12409615
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer.
Fekete M; Wittliff JL; Schally AV
J Clin Lab Anal; 1989; 3(3):137-47. PubMed ID: 2569034
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
Schally AV; Redding TW
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
[TBL] [Abstract][Full Text] [Related]
7. Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.
Kadar T; Redding TW; Ben-David M; Schally AV
Proc Natl Acad Sci U S A; 1988 Feb; 85(3):890-4. PubMed ID: 2893378
[TBL] [Abstract][Full Text] [Related]
8. The effect of large uterine fibroids on urinary bladder function and symptoms.
Langer R; Golan A; Neuman M; Schneider D; Bukovsky I; Caspi E
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1139-41. PubMed ID: 2145766
[TBL] [Abstract][Full Text] [Related]
9. Effect of treatment with LHRH analogs containing cytotoxic radicals on the binding characteristics of receptors for luteinizing-hormone-releasing hormone in MXT mouse mammary carcinoma.
Milovanovic SR; Monje E; Szepeshazi K; Radulovic S; Schally A
J Cancer Res Clin Oncol; 1993; 119(5):273-8. PubMed ID: 8382705
[TBL] [Abstract][Full Text] [Related]
10. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
Gründker C; Völker P; Schulz KD; Emons G
Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
[TBL] [Abstract][Full Text] [Related]
11. Luteolytic effect of D-Trp6-luteinizing hormone-releasing hormone in the rhesus monkey (Macaca mulatta).
Asch RH; Siler-Khodr TM; Smith CG; Schally AV
J Clin Endocrinol Metab; 1981 Mar; 52(3):565-71. PubMed ID: 6450776
[TBL] [Abstract][Full Text] [Related]
12. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
[TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity.
Marchetti B; Guarcello V; Morale MC; Bartoloni G; Raiti F; Palumbo G; Farinella Z; Cordaro S; Scapagnini U
Endocrinology; 1989 Aug; 125(2):1037-45. PubMed ID: 2546733
[TBL] [Abstract][Full Text] [Related]
14. Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients.
Zorn JR; Mathieson J; Risquez F; Comaru-Schally AM; Schally AV
Fertil Steril; 1990 Mar; 53(3):401-6. PubMed ID: 2137792
[TBL] [Abstract][Full Text] [Related]
15. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.
Srkalovic G; Bokser L; Radulovic S; Korkut E; Schally AV
Endocrinology; 1990 Dec; 127(6):3052-60. PubMed ID: 2174343
[TBL] [Abstract][Full Text] [Related]
16. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
[TBL] [Abstract][Full Text] [Related]
17. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
[TBL] [Abstract][Full Text] [Related]
18. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
Pinski J; Lamharzi N; Halmos G; Groot K; Jungwirth A; Vadillo-Buenfil M; Kakar SS; Schally AV
Endocrinology; 1996 Aug; 137(8):3430-6. PubMed ID: 8754771
[TBL] [Abstract][Full Text] [Related]
19. A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man.
Evans RM; Doelle GC; Lindner J; Bradley V; Rabin D
J Clin Invest; 1984 Jan; 73(1):262-6. PubMed ID: 6228566
[TBL] [Abstract][Full Text] [Related]
20. D-TRP5-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty.
Laron Z; Kauli R; Zeev ZB; Comaru-Schally AM; Schally AV
Lancet; 1981 Oct; 2(8253):955-6. PubMed ID: 6117727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]